KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cvs Health (CVS) Goodwill (2016 - 2025)

Historic Goodwill for Cvs Health (CVS) over the last 17 years, with Q4 2025 value amounting to $85.5 billion.

  • Cvs Health's Goodwill fell 634.81% to $85.5 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $85.5 billion, marking a year-over-year decrease of 634.81%. This contributed to the annual value of $85.5 billion for FY2025, which is 634.81% down from last year.
  • Latest data reveals that Cvs Health reported Goodwill of $85.5 billion as of Q4 2025, which was down 634.81% from $85.5 billion recorded in Q3 2025.
  • Cvs Health's Goodwill's 5-year high stood at $91.3 billion during Q4 2023, with a 5-year trough of $78.1 billion in Q3 2022.
  • Its 5-year average for Goodwill is $85.4 billion, with a median of $85.5 billion in 2025.
  • Per our database at Business Quant, Cvs Health's Goodwill surged by 1687.24% in 2023 and then crashed by 634.81% in 2025.
  • Over the past 5 years, Cvs Health's Goodwill (Quarter) stood at $79.1 billion in 2021, then dropped by 1.23% to $78.2 billion in 2022, then increased by 16.79% to $91.3 billion in 2023, then changed by 0.0% to $91.3 billion in 2024, then decreased by 6.35% to $85.5 billion in 2025.
  • Its Goodwill was $85.5 billion in Q4 2025, compared to $85.5 billion in Q3 2025 and $91.2 billion in Q2 2025.